SMTL ID : 3v5m.1

Crystal structure of M69V mutant of SHV beta-lactamase

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.30 Å

Oligo State

monomer

Ligands

2 x MA4: CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE(Non-covalent)

MA4.1: 13 residues within 4Å: Chain A: I.196, V.199, P.201, I.206, A.222, V.234, I.236, I.252, A.253, A.257, I.260, E.261 Ligands: MA4.2 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.196, A:I.206, A:A.222, A:V.234, A:I.236, A:I.252 Hydrogen bonds: A:E.261 MA4.2: 6 residues within 4Å: Chain A: L.195, R.218, N.249, I.252, A.253 Ligands: MA4.1 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.195, A:I.252, A:A.253

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ke, W. et al., The importance of the trans-enamine intermediate as a beta-lactamase inhibition strategy probed in inhibitor-resistant SHV beta-lactamase variants. Chemmedchem (2012)

Release Date

2012-08-08

Peptides

Beta-lactamase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Beta-lactamase